Pope Resigns 2013 - Pope Benedict XVI Resigns 2013 - Resignation of Pope Benedict XVI - 2/11/13 Pope Resigns 2013 - Pope Benedict XVI Resigns 2013 - Resignation of Pope Benedict XVI Vatican - 2/11/13 Resignation ROME mdash; Citing advanced years and infirmity, Pope Benedict XVI, the former Cardinal Joseph Ratzinger, stunned the Roman Catholic world on Monday by saying that he would resign on Feb. 28, less than eight years after he took office, the first pope to do so in six centuries. A profoundly conservative figure whose papacy was overshadowed by clerical abuse scandals, the pope, 85, was elected by fellow cardinals in 2005 after the death of his predecessor, John Paul II. After examining his conscience "before God," he said on Monday, "I have come to the certainty that my strengths, due to an advanced age, are no longer suited to an adequate exercise" of his position as head of the world's Roman Catholics. Federico Lombardi, the Vatican spokesman, said Benedict would continue to carry out his papal duties until Feb. 28 and that a successor could probably be elected by Easter which falls this year on March 31. But, he added, that date was "not … Continue reading →

Oratory Contest Grand Rapids Right to Life will sponsor the 24th Annual Prolife Oratory Contest. This is a great way for high school students to practice their research and public speaking skills. Each student who enters the contest will prepare a 5-7 minute speech on one of these prolife issues: Abortion, Infanticide, Euthanasia, Human Cloning, or Embryonic Stem Cell Research. The top three finalists will earn cash prizes! Details at: grrtl.org By: GRRTL … Continue reading →

Regenerative medicine and Stem cells Partnering Terms and Agreements is the new market research report added to ReportsnReports.com store. Dallas, TX (PRWEB) February 12, 2013 The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine and stem cells partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors regenerative medicine and stem cells technology. These deals tend to be multi component, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest regenerative medicine and stem cells agreements including cell therapy agreements announced in the healthcare sector. Understanding the flexibility of a prospective partners negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered contract documents provide this insight where press releases and databases do not. This report contains a comprehensive listing of all regenerative medicine and stem cells partnering deals announced since 2008 including financial terms were … Continue reading →

Stem cells of the aging bone marrow recycle their own molecules to survive and keep replenishing the blood and immune systems as the body ages, researchers at UC San Francisco (UCSF) have discovered. The recycling process, known as autophagy, or self-eating, involves reusing molecules and the chemical energy obtained from these molecules to withstand the killing effect of metabolic stress that intensifies as the body ages. Emmanuelle Passegu, PhD The discovery, reported online Feb. 6 in the journal Nature, showed that autophagy allows stem cells to avoid the alternative response to stress, which is programmed cellular suicide, in which cells that arent up to snuff kill themselves for the greater good. While this trick of autophagy may help delay the onset of anemia, immune-system failure and other maladies that occur with age, as a survival strategy it is a bit of a compromise, said the senior author of the study, Emmanuelle Passegu, PhD, of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF. Autophagy might increase cancer risk, she said, by allowing old stem cells to survive despite having accumulated risky mutations over a lifetime. Almost all blood malignancies start in the stem cell … Continue reading →

BEVERLY, MA and TORONTO--(Marketwire - Feb 11, 2013) - Hamilton Thorne Ltd. ( TSX VENTURE : HTL ), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year-ended December 31, 2012. "Our preliminary unaudited results show that Hamilton Thorne's fourth quarter sales increased to approximately $2.05 million, up 41% versus the third quarter of 2012 and up 2% versus the same quarter last year," said David Wolf, President and Chief Executive Officer of Hamilton Thorne Ltd."More importantly, we generated approximately $150,000 of positive cash flow for the quarter due to the combination of strong sales and the full impact of the strategic cost cutting that we executed in the third quarter." Sales growth was driven by increased demand for the Hamilton Thorne's best-of-class CASA II image analysis systems which were introduced at the end of the third quarter and shipped in quantity in Q4.Total preliminary sales for the year were approximately $6.3 million. Mr. Wolf continued, "In 2013, we expect to continue to invest in product enhancements and sales and marketing activities, in order to … Continue reading →

Public release date: 11-Feb-2013 [ | E-mail | Share ] Contact: Tara Womersley tara.womersley@ed.ac.uk 44-131-650-9836 University of Edinburgh A discovery using stem cells from a patient with motor neurone disease could help research into treatments for the condition. The study used a patient's skin cells to create motor neurons - nerve cells that control muscle activity - and the cells that support them called astrocytes. Researchers studied these two types of cells in the laboratory. They found that a protein expressed by abnormalities in a gene linked to motor neurone disease, which is called TDP-43, caused the astrocytes to die. The study, led by the University of Edinburgh and funded by the Motor Neurone Disease Association, provides fresh insight into the mechanisms involved in the disease. Although TDP-43 mutations are a rare cause of motor neurone disease (MND), scientists are especially interested in the gene because in the vast majority of MND patients, TDP-43 protein (made by the TDP-43 gene) forms pathological clumps inside motor neurons. Motor neurons die in MND leading to paralysis and early death. This study shows for the first time that abnormal TDP-43 protein causes death of astrocytes. The researchers, however, found that the damaged astrocytes … Continue reading →